Debbie Orcutt
Debbie Orcutt, diagnosed with aggressive pancreatic cancer in 2024, participated in a clinical trial for an experimental drug, daraxonrasib, after being given limited treatment options. Her tumors shrank by 64%, raising hopes for innovative cancer therapies.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Greece:
Debbie Orcutt was diagnosed with pancreatic cancer and decided to participate in a clinical trial for an experimental drug.
7